Brief: Ajanta Pharma's Formulation Facility At Dahej Inspected By U.S. FDA
July 27 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA
FROM
23 JULY, 2018 TO 27 JULY, 2018
Source text: http://bit.ly/2LtbD35
Further company coverage: AJPH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility